Serum S100B correlates with health-related quality of life and functional outcome in patients at 1 year after aneurysmal subarachnoid haemorrhage.

Aineskog, Helena; Johansson, Conny; Nilsson, Robert; Koskinen, Lars-Owe D; Lindvall, Peter

Aineskog, Helena; Johansson, Conny; Nilsson, Robert; Koskinen, Lars-Owe D; Lindvall, Peter.

Afiliação

Aineskog H; Department of Clinical Sciences - Neurosciences, Umeå University, 901 87, Umeå, Sweden. Helena.Aineskog@regionvasterbotten.se.
Johansson C; Department of Clinical Sciences - Neurosciences, Umeå University, 901 87, Umeå, Sweden.
Nilsson R; Department of Clinical Sciences - Neurosciences, Umeå University, 901 87, Umeå, Sweden.
Koskinen LD; Department of Clinical Sciences - Neurosciences, Umeå University, 901 87, Umeå, Sweden.
Lindvall P; Department of Clinical Sciences - Neurosciences, Umeå University, 901 87, Umeå, Sweden.

Acta Neurochir (Wien) ; 164(8): 2209-2218, 2022 08.

Article em En | MEDLINE | ID: mdl-35748928

Assuntos

Hemorragia Subaracnóidea; Biomarcadores; Humanos; Prognóstico; Qualidade de Vida; Curva ROC; Subunidade beta da Proteína Ligante de Cálcio S100; Hemorragia Subaracnóidea/diagnóstico

Palavras-chave

EQ-5D-3L: EuroQoL health-related quality of life; Modified ranking scale; S100B; Subarachnoid haemorrhage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Subaracnóidea Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Acta Neurochir (Wien) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google